Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn Owen

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Haematologica|August 28, 2025
The age of fit-equity: ignoring age and fitness in treatment selection for chronic lymphocytic leukemiaCarolyn Owen
Haematologica|May 25, 2011
Familial myelodysplastic syndromes: a review of the literatureElena Liew, Carolyn Owen
Biologics : Targets & Therapy|March 4, 2015
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemiaSonia Cerquozzi, Carolyn Owen
Expert Opinion on Biological Therapy|January 31, 2012
Obinutuzumab for the treatment of lymphoproliferative disordersCarolyn Owen, Douglas A Stewart
Hematological Oncology|December 17, 2009
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemiaCarolyn Owen, Jude Fitzgibbon, Peter Paschka
European Journal of Haematology|December 27, 2024
Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic LeukemiaRobert Puckrin, Carolyn Owen, Anthea Peters
British Journal of Haematology|January 5, 2008
Familial myelodysplasia and acute myeloid leukaemia--a reviewCarolyn Owen, Michael Barnett, Jude Fitzgibbon
Seminars in Oncology Nursing|July 20, 2021
Treating CLL with Bruton Tyrosine Kinase Inhibitors: The Role of the Outpatient Oncology NurseBaljit Randhawa, Ellen Lewis, Carolyn Owen
Anticancer Research|May 17, 2002
JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascades as a means to understand their in vivo biological roleKostas D Katsanakis, Carolyn Owen, Vassilis Zoumpourlis
Current Oncology (Toronto, Ont.)|June 23, 2022
A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological MalignanciesCarolyn Owen, Sue Robinson, Anna Christofides, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Haematologica|August 28, 2025
The age of fit-equity: ignoring age and fitness in treatment selection for chronic lymphocytic leukemiaCarolyn Owen
Haematologica|May 25, 2011
Familial myelodysplastic syndromes: a review of the literatureElena Liew, Carolyn Owen
Biologics : Targets & Therapy|March 4, 2015
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemiaSonia Cerquozzi, Carolyn Owen
Expert Opinion on Biological Therapy|January 31, 2012
Obinutuzumab for the treatment of lymphoproliferative disordersCarolyn Owen, Douglas A Stewart
Hematological Oncology|December 17, 2009
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemiaCarolyn Owen, Jude Fitzgibbon, Peter Paschka
European Journal of Haematology|December 27, 2024
Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic LeukemiaRobert Puckrin, Carolyn Owen, Anthea Peters
British Journal of Haematology|January 5, 2008
Familial myelodysplasia and acute myeloid leukaemia--a reviewCarolyn Owen, Michael Barnett, Jude Fitzgibbon
Seminars in Oncology Nursing|July 20, 2021
Treating CLL with Bruton Tyrosine Kinase Inhibitors: The Role of the Outpatient Oncology NurseBaljit Randhawa, Ellen Lewis, Carolyn Owen
Anticancer Research|May 17, 2002
JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascades as a means to understand their in vivo biological roleKostas D Katsanakis, Carolyn Owen, Vassilis Zoumpourlis
Current Oncology (Toronto, Ont.)|June 23, 2022
A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological MalignanciesCarolyn Owen, Sue Robinson, Anna Christofides, et al.
Pageof 8